Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Worrying results from genotyping quality assessments

Published: 14 Dec 2017

Rating:

Save

Prof David Barton - National Centre for Medical Genetics, Dublin, Ireland

David Barton talks to ecancer at EAPM 2017 in Belfast.

He discusses the need for better quality in genetic testing of tumour and patient genotyping.

He explains how by running assessments of the quality of this genotyping, he sees a worrying number of incorrect results, particularly with the adoption of new technologies.

These are mainly due to simple human errors.

Related Videos

Tele-mentoring: Impact of project ECHO

Dr Sanjeev Arora - Project ECHO, Albuquerque, USA

22 Oct 2024

OncoAlert Round Up for September 15-21, 2023

Dr Gil Morgan - Executive Director, OncoAlert

25 Sep 2023

Choosing Wisely in pathology

Dr Angela Mlole - Ocean Road Cancer Institute, Dar es Salaam, Tanzania

18 May 2023

Choosing Wisely in radiology Tanzania

Dr Revelian Iramu - Ocean Road Cancer Institute, Dar es Salaam, Tanzania

18 May 2023

Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours

Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA

25 Apr 2023

Choosing Wisely to mitigate financial toxicity in cancer care in Africa

Dr Penina Mnandi - Ocean Road Cancer Institute, Dar es Salaam, Tanzania

22 Mar 2023

Global adoption of single-shot targeted IORT for breast cancer

Dr Jayant Vaidya - University College London, London, UK

9 Mar 2023

Moving to the future: Artificial intelligence in surgery

Dr Maria João Cardoso - Champalimaud Cancer Centre, Lisbon, Portugal

31 Jan 2023

Gemtuzumab ozogamicin plus chemotherapy improves outcomes in intermediate-risk cytogenetic AML

Dr Eunice Wang - Roswell Park Comprehensive Cancer Center, New York, USA

22 Dec 2022

Worrying results from genotyping quality assessments

Related Videos

More from ecancer